From guidelines to practice: LDL-C achievement in very high cardiovascular risk patients – analysis of the EDHIPO MARCA registry

Abstract Background Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with dyslipidemia playing a key role in its progression. Despite advances in lipid-lowering therapy (LLT), LDL-C (Low-Density Lipoprotein Cholesterol) goal achievement remains suboptimal. This...

Description complète

Détails bibliographiques

Auteurs principaux:	Brayan Daniel Cordoba-Melo, Sebastián Seni-Molina, Juan Pablo Arango-Ibanez, Milton René Ayala, José Fidel Tatis-Méndez, Viviana Quintero Yepez, Luz Aída Mejía Cadavid, José D. Cruz-Cuevas, Nicolás Ariza-Ordóñez, Andrés Buitrago, Jose Patricio Lopez-Lopez, Alfredo Hinestrosa, Jorge Sabogal, Cristian Reyes-Vargas, Álvaro Herrera-Escandon, Juan Sebastián Hurtado, Juan Fernando Velásquez Osorio, Sergio Londoño, Carlos Salamanca, Liliana Vallecilla, Hoover Leon-Giraldo, Alvaro J. Ruiz, Dora Inés Molina, Juan Esteban Gomez-Mesa, On Behalf of EDHIPO MARCA Research Group
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-09-01
Collection:	Lipids in Health and Disease
Sujets:	LDL-C goal Very high cardiovascular risk Lipid-lowering therapy ESC/EAS guidelines
Accès en ligne:	https://doi.org/10.1186/s12944-025-02657-9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!